ASG vs BRK-B

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and an absent Altman Z-Score, preventing a full distress risk assessment. Despite a low P/E of 9.54 compared to the sector average of 21.57 and a Price/Book of 0.90 suggesting possible value appeal, the company faces severe operational challenges, including negative operating margin (-125.62%) and steep year-over-year declines in revenue (-13.20%) and earnings (-80.60%). The high dividend yield of 8.94% appears unsustainable given the 82.14% payout ratio amid falling earnings, while technical indicators signal a bearish trend. Although the stock trades above the Graham Number of $8.64, current price of $5.34 appears misleadingly low due to deteriorating fundamentals and lack of analyst coverage.

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.